This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
27-29 April 2027
Congress Center HamburgHamburg, Germany
Book Now
Menu
Book Now
Key Sessions
Vittoria Carraro
The European Biotech Act: What’s in it for the European Biotech sector?
European Commission
Peter Neubauer
The Future of Self-Driving Laboratories as Innovative Entities to Revolutionise Bioprocess Development
Berlin University of Technology (TU Berlin), Germany
Andrea Johnston, PhD
[BioPhorum Case Study] The Future of Manufacturing Operations
BioPhorum
keyboard_arrow_right

Main Conference Day 1 (28th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search
Main Conference Day 1 (28th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
Showing 1 of 1 Streams
08:55 - 09:00
Chairperson's Opening Remarks
  • Margit Holzer - Scientific Director, Ulysse Consult
09:00 - 09:30
Towards Platform Processes in Downstream Processing of Viral Gene Therapy Vectors
  • Alois Jungbauer - Professor, Dept. of Biotechnology, BOKU University
09:30 - 10:00
Beyond the Blueprint: Tailoring DSP for a therapeutic protein
  • Hubert Mayerhofer - Senior Manager DSP Development, Novartis
10:00 - 10:30
Breaking the Downstream Bottleneck: Enabling Sub $50/g, Cost Effective mAb Manufacturing Through Integrated Continuous BioProcessing
  • Jean-Marc Cappia - Head of Business Development Downstream Process Intensification, Sartorius
Showing 1 of 1 Streams
11:15 - 11:45
Lord of the Rings: Optimisation of a Plasmid Purification Process Combining HTS and Mechanistic Modelling
  • Sabrina Simpson-Koch - Senior Scientist - Gene Therapy Technical Research & Development, Roche
11:45 - 12:15
PANEL DISCUSSION: Emerging Purification Strategies for Extracellular Vesicles (EVs) and Exosomes

  • EVs are rapidly growing, but with no established purification platform

  • Current state-of-the-art purification strategies

  • Pros and Cons of differing approaches:

    • Centrifugation

    • Filtration

    • Chromatography

  • The future of EV purification: what will a platform look like?

  • Bernd Giebel - Professor for Translational EV research, University Hospital Essen of the University of Duisburg-Essen
  • Patricia Pereira Aguilar - Senior Scientist – Institute of Bioprocess Science and Engineering, BOKU
  • Jack Cordrey - Senior Bioprocessing Specialist, Thermo Fisher Scientific
12:15 - 12:45
Developing Bespoke Purification Strategies for Challenging Biologics: A Case Study.
  • Christopher Fox - Senior Technical Project Leader, Process Development, FUJIFILM Biotechnologies
Pre-Con Workshop Day (27th April 2026)
NextMain Conference Day 2 (29th April 2026)
Filter
Streams
Clear
Choose Day